Nobuo Hanai

7.8k total citations · 2 hit papers
102 papers, 6.5k citations indexed

About

Nobuo Hanai is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Nobuo Hanai has authored 102 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 44 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Immunology. Recurrent topics in Nobuo Hanai's work include Glycosylation and Glycoproteins Research (51 papers), Monoclonal and Polyclonal Antibodies Research (42 papers) and Galectins and Cancer Biology (15 papers). Nobuo Hanai is often cited by papers focused on Glycosylation and Glycoproteins Research (51 papers), Monoclonal and Polyclonal Antibodies Research (42 papers) and Galectins and Cancer Biology (15 papers). Nobuo Hanai collaborates with scholars based in Japan, United States and Australia. Nobuo Hanai's co-authors include Kenya Shitara, Kazuyasu Nakamura, Hideharu Anazawa, Toyohide Shinkawa, Kazuhisa Uchida, Mitsuo Satoh, Akiko Furuya, Motoo Yamasaki, Tatsunari Nishi and Yutaka Kanda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Nobuo Hanai

102 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity

2003 1.1k citations Toyohide Shinkawa, Kazuyasu Nakamura et al. Journal of Biological Chemistry profile →
Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells.

1993 678 citations Nobuo Hanai et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nobuo Hanai Japan	37	4.1k	2.1k	1.7k	823	801	102	6.5k
Tsutomu Tsuji Japan	37	2.4k 0.6×	1.0k 0.5×	463 0.3×	503 0.6×	536 0.7×	168	4.9k
Dennis J. Mitchell United States	34	3.7k 0.9×	4.1k 2.0×	1.0k 0.6×	917 1.1×	266 0.3×	44	8.7k
John Hood United States	30	4.2k 1.0×	648 0.3×	448 0.3×	1.1k 1.4×	542 0.7×	56	7.2k
Åke Wasteson Sweden	40	4.5k 1.1×	826 0.4×	555 0.3×	1.0k 1.3×	397 0.5×	88	7.6k
In‐San Kim South Korea	50	4.6k 1.1×	1.5k 0.7×	363 0.2×	1.0k 1.2×	354 0.4×	166	7.7k
Suzanne M. Watt United Kingdom	46	2.8k 0.7×	1.2k 0.6×	536 0.3×	1.1k 1.3×	367 0.5×	145	6.6k
Anthony P. Albino United States	48	3.4k 0.8×	1.3k 0.6×	575 0.3×	2.5k 3.1×	257 0.3×	115	6.6k
Peter N. Monk United Kingdom	44	2.1k 0.5×	2.6k 1.2×	771 0.5×	481 0.6×	516 0.6×	127	6.2k
Ralph Schwall United States	48	6.1k 1.5×	1.4k 0.7×	1.4k 0.8×	2.7k 3.2×	167 0.2×	85	10.2k
Reuven Reich Israel	59	5.4k 1.3×	1.8k 0.9×	346 0.2×	3.0k 3.7×	461 0.6×	202	11.2k

Countries citing papers authored by Nobuo Hanai

Since Specialization

Citations

This map shows the geographic impact of Nobuo Hanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Hanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Hanai more than expected).

Fields of papers citing papers by Nobuo Hanai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Hanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Hanai. The network helps show where Nobuo Hanai may publish in the future.

Co-authorship network of co-authors of Nobuo Hanai

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Hanai. A scholar is included among the top collaborators of Nobuo Hanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Hanai. Nobuo Hanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kubota, Tsuguo, Rinpei Niwa, Mitsuo Satoh, et al.. (2009). Engineered therapeutic antibodies with improved effector functions. Cancer Science. 100(9). 1566–1572. 117 indexed citations

Satoh, Mitsuo, Kenya Shitara, & Nobuo Hanai. (2006). The Current Stream and Prospect of Glycoscience Application-Therapeutic Antibodies-. Trends in Glycoscience and Glycotechnology. 18(100). 129–136. 10 indexed citations

Shinkawa, Toyohide, Kazuyasu Nakamura, Yutaka Kanda, et al.. (2003). The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity. Journal of Biological Chemistry. 278(5). 3466–3473. 1126 indexed citations breakdown →

Shibata, Kenji, Toshiyuki Suzawa, Shiro Soga, et al.. (2003). Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide. Bioorganic & Medicinal Chemistry Letters. 13(15). 2583–2586. 19 indexed citations

Shimoyama, Manabu, Hiroshi Matsuoka, Mitsuhiro Ito, et al.. (2000). T-Cell-Specific Expression of Kinase-Defective Eph -Family Receptor Protein, EphB6 in Normal as well as Transformed Hematopoietic Cells. Growth Factors. 18(1). 63–78. 36 indexed citations

Yoshikawa, Kazuhiro, Kazuyasu Nakamura, Nobuo Hanai, et al.. (2000). Production of a Single‐chain Variable Fragment Antibody Recognizing Type III Mutant Epidermal Growth Factor Receptor. Japanese Journal of Cancer Research. 91(10). 1035–1043. 23 indexed citations

Hanai, Nobuo, Kazuyasu Nakamura, & Kenya Shitara. (2000). Recombinant antibodies against ganglioside expressed on tumor cells. Cancer Chemotherapy and Pharmacology. 46(S1). S13–S17. 29 indexed citations

Tsuiki, Hiromasa, Masayuki Nitta, Akiko Furuya, et al.. (2000). A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis. Journal of Cellular Biochemistry. 76(2). 254–269. 73 indexed citations

Nagata, Kisaburo, Tsutomu Tsuji, Kouji Matsushima, Nobuo Hanai, & Tatsuro Irimura. (2000). Redistribution of selectin counter-ligands induced by cytokines. International Immunology. 12(4). 487–492. 11 indexed citations

10.

Takahashi, Mutsuo, et al.. (1999). Immunohistochemical, conventional and immunoelectron microscopical characteristics of periodic acid-Schiff-positive granules in the mouse brain. Acta Neuropathologica. 98(1). 31–38. 23 indexed citations

11.

Nagata, Kyosuke, Shoko Saito, Mitsuru Okuwaki, et al.. (1998). Cellular Localization and Expression of Template-Activating Factor I in Different Cell Types. Experimental Cell Research. 240(2). 274–281. 106 indexed citations

12.

Numasaki, Muneo, Kazuyasu Nakamura, Yoshihiro Fukuoka, et al.. (1998). Nucleotide sequence analysis of a human monoclonal antibody 22-13 reactive with lung tumor-associated antigen. Immunology Letters. 60(2-3). 111–120. 1 indexed citations

13.

Huang, Jingqi, Jacquetta M. Trasler, Suleiman A. Igdoura, et al.. (1997). Apoptotic Cell Death in Mouse Models of GM2 Gangliosidosis and Observations on Human Tay-Sachs and Sandhoff Diseases. Human Molecular Genetics. 6(11). 1879–1885. 129 indexed citations

14.

Fukuda, Mitsugu, Akio Ishii, Nobuko Shimada, et al.. (1996). Decreased expression of nucleoside diphosphate kinase α isoform, annm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells. International Journal of Cancer. 65(4). 531–537. 61 indexed citations

15.

Nishio, Kazuto, et al.. (1996). Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody. International Journal of Cancer. 67(5). 676–680. 14 indexed citations

16.

Häyrinen, Jukka, Harold J. Jennings, Howard V. Raff, et al.. (1995). Antibodies to Polysialic Acid and its N-Propyl Derivative: Binding Properties and Interaction with Human Embryonal Brain Glycopeptides. The Journal of Infectious Diseases. 171(6). 1481–1490. 87 indexed citations

17.

Shitara, Kenya, et al.. (1994). A new vector for the high level expression of chimeric antibodies in myeloma cells. Journal of Immunological Methods. 167(1-2). 271–278. 12 indexed citations

18.

Ohta, So, Nobuo Hanai, Sonoko Habu, & Takashi Nishimura. (1993). Expression of Sialyl Lewisx Antigen on Human T Cells. Cellular Immunology. 151(2). 491–497. 13 indexed citations

19.

Koyanagi, Akemi, Akiko Furuya, Yutaka Iigo, et al.. (1990). Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. International Immunology. 2(7). 677–684. 79 indexed citations

20.

Hanai, Nobuo. (1984). Morphological and immunocytochemical study of rat pancreatic beta cell changes induced by cyclizine. Journal of Applied Toxicology. 4(6). 308–314. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact